Allogene Therapeutics, Inc.

Ownership Transactions Reported by 22 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+1.72M	97.3%	$2.90	+$5M
Sells	2	-48.5K	2.7%	$2.45	-$119K
Net	0	+1.68M	94.5%		+$4.88M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Tpg Gp A, Llc	10%+ Owner	$59.4M			Jan 12, 2022
David D. Chang	President and CEO, Director	$16.4M			May 16, 2024
Arie Belldegrun	Director	$10.4M	+$5M	+92.4%	May 16, 2024
Eric Schmidt	Chief Financial Officer	$6.4M			Mar 22, 2023
Geoffrey M. Parker	Chief Financial Officer	$3.38M	+$683	+0.02%	May 16, 2024
Alison Moore	Chief Technical Officer	$2.14M			Mar 22, 2023
Veer Bhavnagri	General Counsel	$1.77M			Mar 14, 2023
Rafael Amado	EVP of R&D	$1.72M			Oct 7, 2022
Zachary Roberts	EVP of R&D	$1.64M			Jan 25, 2024
Earl Douglas	SVP, General Counsel	$1.25M			Aug 21, 2024
N. Witte	Director	$930K			Jun 5, 2024
Timothy L. Moore	Chief Technical Officer	$920K			Apr 22, 2024
Franz B. Humer	Director	$740K	-$26.2K	-3.42%	Jun 5, 2024
Lillian Smith	VP, Corporate Counsel	$446K			Apr 1, 2023
Deborah M. Messemer	Director	$380K	-$92.8K	-19.6%	Jun 18, 2024
Vicki L. Sato	Director	$380K			Jun 5, 2024
Yinlin Jack Chen	SVP, Finance	$282K			Aug 10, 2023
Annie Yoshiyama	SVP, Finance	$238K			Jun 5, 2024
Stephen Mayo	Director	$80.4K			Jun 5, 2024
PF Equity Holdings 2 B.V.	10%+ Owner				Mar 31, 2022
Elizabeth Barrett	Director				Jun 5, 2024
Joshua A. Kazam	Director				Jun 5, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.